Defense Advanced Research Projects AgencyTagged Content List

Restore and Maintain Warfighter Abilities

Relating to the restoration and optimization of human health

Showing 5 results for Health + Events RSS
March 20, 2018,
Webinar
DARPA’s Biological Technologies Office is hosting an online-only Proposers Day webinar to provide information to potential applicants on the structure and objectives of the new Biostasis program. Biostasis aims to extend the time for lifesaving medical treatment following traumatic injury or acute infection by developing novel, non-thermal, molecular interventions to reversibly slow and/or pause the functions of living cells and preserve their viability.
February 22, 2017,
Crown Plaza Tysons Corner-McLean
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Pandemic Prevention Platform (P3) program. P3 aims to develop an integrated, end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in 60 days or less. Performers will use nucleic-acid-based technologies pioneered by DARPA as a foundation for work to overcome the remaining bottlenecks preventing rapid response to pandemic threats.
March 2, 2017,
Doubletree by Hilton San Diego Downtown
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Pandemic Prevention Platform (P3) program. P3 aims to develop an integrated, end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in 60 days or less. Performers will use nucleic-acid-based technologies pioneered by DARPA as a foundation for work to overcome the remaining bottlenecks preventing rapid response to pandemic threats.
June 13, 2018,
Westin Arlington Gateway Hotel
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new PReemptive Expression of Protective Alleles and Response Elements (PREPARE) program. PREPARE will explore ways to better protect against biological, chemical, or radiological threats by temporarily and reversibly tuning gene expression to bolster the body’s defenses against—or directly neutralize—a given threat. It will focus on four key health challenges as proofs of concept: influenza viral infection, opioid overdose, organophosphate poisoning, and exposure to gamma radiation.
June 27, 2016,
Offsite
DARPA’s Biological Technologies Office (BTO) is hosting a Proposers Day to provide information to potential proposers on the objectives of the upcoming Prometheus program. The program aims to discover host prognostic biomarkers of acute respiratory infection that predict if a person will become contagious after infection, but prior to the onset of symptoms. A key aspect of the program will be to characterize human immune responses at multiple time points during infection.